ArticleAmerican journal of translational research2025
Clinical efficacy of soft-shelled turtle shell and salt moxibustion in improving kidney yang deficiency-type Laolin in middle-aged and elderly women.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical efficacy of Soft-Shelled Turtle Shell and Salt Moxibustion in treating kidney yang deficiency-type Laolin in middle-aged and elderly women and assessing treatment impact on quality of life.
methodsA retrospective analysis was conducted on 72 middle-aged and elderly female patients with kidney yang deficiency-type Laolin treated at Suzhou Hospital of Traditional Chinese Medicine between June 2023 and April 2024 (research group). Patients with the same condition who received only basic treatment and care served as the control group. The research group received Soft-Shelled Turtle Shell and Salt Moxibustion in addition to the control treatment. Outcomes including traditional Chinese medicine (TCM) syndrome scores, clinical efficacy, immunoglobulin M (IgM), immunoglobulin G (IgG), routine urine white blood cell count, urine bacterial counts, quality of life scores, and complication rates were compared between the two groups.
resultsThe research group demonstrated significantly greater improvement in TCM syndrome scores, clinical efficacy, and urine bacterial counts compared to the control group (all P<0.05). Post-treatment IgM and IgG levels were also significantly higher in the research group (both P<0.05). Additionally, the research group exhibited a more pronounced reduction in urine white blood cell counts and achieved significantly higher quality of life scores (both P<0.05). The incidence of adverse reactions in the research group was lower than that in the control group (P<0.05). Patient satisfaction with care was notably higher in the research group (P<0.05).
conclusionSoft-Shelled Turtle Shell and Salt Moxibustion is highly effective in treating middle-aged and elderly female patients with kidney yang deficiency-type Laolin. It significantly improves TCM syndrome scores, immunoglobulin levels, urine bacterial counts, and routine urine white blood cell counts while enhancing patients' quality of life. The therapy is safe, with minimal and self-limiting adverse reactions, primarily mild skin irritation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.